Purchase Order 75N95020P00562
Award Date 9/14/20
Potential Completion Date 11/30/20
Potential Value $29K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $33,560 purchase order to Antibodies Incorporated for two monoclonal antibody projects. Antibodies Incorporated, doing business as Antibodies Inc., will deliver the requested monoclonal antibodies from its Bethesda, Maryland facility within the one-month period of performance ending September 30, 2023. As the prime contractor, Antibodies Inc. will be responsible for completion of the two...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $14,630.25 contract is for the development of monoclonal antibodies to support biomedical research. Precision Antibody has provided similar services to HHS components like the National Cancer Institute and Department of...
- This is a $23,086.75 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc., doing business as Precision Antibody. Precision Antibody is a for-profit manufacturer of goods that provides custom antibody development services to support biomedical research. This contract is not set aside for small businesses. The award supports research efforts through the...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency under the National Institutes of Health (NIH), to Cell Signaling Technology, Inc., a for-profit manufacturer of scientific research products. The $24,873.36 contract is for the delivery of antibodies to support ongoing experiments at NIDA's lab. No set-aside designation was used for this award. Cell Signaling Technology, Inc. has a history of securing NIH contract awards to...
- This federal contract award is for the delivery of various antibodies to the National Institute of Allergy and Infectious Diseases, which is part of the Department of Health and Human Services' National Institutes of Health. The contract was awarded to Abcam Inc., a manufacturer of goods and for-profit organization that has previously provided research supplies, including monoclonal antibodies, ELISA kits, conjugated antibodies, and custom antibody services, to federal agencies such as the...
- This is a firm fixed-price purchase order valued at $7,017.50 awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services (HHS) to Affymetrix, Inc. for the delivery of antibodies. The contract does not have a set-aside designation. The award indicates that Affymetrix, Inc. is registered in the System for Award Management (SAM) until March 2018 and is classified as a for-profit manufacturer of goods. No additional details about...
- This is a $98,517.25 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other products supporting life science research and drug discovery. The contract, awarded on January 28, 2021, is for the procurement of COVID-19 research antibodies, with a period of performance through January 26, 2022....
- This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) to Pacific Immunology, a U.S. biotech company located in Ramona, California. The $4,436.81 contract is for the production and delivery of monospecific antibodies and related services to support biomedical research. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of NIH, and does not utilize a small business set-aside. The services to...
- This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
- This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Antibodies Incorporated, a small business manufacturer and distributor of antibodies, diagnostics, and laboratory services. The $29,292.00 contract is for the provision of KDEL receptor antibodies, which are used in biomedical research. This award was issued under a total small business set-aside solicitation, and Antibodies Incorporated has a history of providing similar antibodies and services to the National Institutes of Health. The contract has a period of performance through November 30, 2020.
Generated 9/10/25, 9:59 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
KDEL receptor antibodies | 75N95020Q00192 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Pre-Solicitation 1/3 | 7/29/20, 11:28 AM | |
KDEL receptor antibodies | 75N95020Q00192 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 2/3 | 8/24/20, 11:49 AM | |
KDEL receptor antibodies | 75N95020P00562 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 3/3 | 9/14/20, 12:03 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($7k) | 9/9/25 | |
| P00001 | Funding Only Action | ($3k) | 8/19/25 | |
| Not listed | Not listed | $38.9k | 9/14/20 |